Introduction: We used habitat radiomics as an innovative tumor biomarker to predict the outcome of neoadjuvant therapy for esophageal cancer. Methods: This was a two-center retrospective clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback